5-Amino-1MQ (10 mg Vial) Dosage Protocol
5-Amino-1MQ (10 mg Vial) Dosage Protocol
Quickstart Highlights
5-Amino-1MQ dosing strategies are built around its role as a selective, cell-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), a mechanism that has been explored in research settings for potential effects on fat metabolism, maintenance of lean muscle tissue, and support of intracellular NAD⁺ concentrations. Through inhibition of NNMT activity, 5-Amino-1MQ may contribute to improved cellular energy homeostasis and engagement of SIRT1-related pathways linked to metabolic efficiency. This educational overview describes a subcutaneous administration method intended to enhance systemic availability when working with the 50 mg vial presentation.
- Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL concentration.
- Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).
- Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg on a U-100 insulin syringe.
- Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.
Dosing & Reconstitution Guide
Educational overview for reconstitution and daily dosing practices
Subcutaneous Protocol (2 mL = 5 mg/mL)
| Phase | Daily Dose (mg) | Units (per injection) (mL) |
|---|---|---|
| Days 1–2 (Tolerance) | 2.5 mg once daily | 50 units (0.50 mL) |
| Days 3–4 (Standard) | 5 mg once daily | 100 units (1.0 mL) |
| Alternative BID | 2.5 mg twice daily | 50 units (0.50 mL) × 2 |
Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours, twice-daily (BID) dosing may provide more sustained NNMT inhibition. Note: A single 10 mg vial provides only 2–4 days of research material at these doses.
Reconstitution Steps
- Remove the vial from frozen storage (−20 °C / −4 °F) and allow it to sit at room temperature for approximately 15–20 minutes before reconstitution.
- Using a sterile syringe, withdraw 2.0 mL of bacteriostatic water.
- Introduce the diluent slowly along the inside wall of the vial to minimize foaming.
- Gently swirl or roll the vial until the contents are fully dissolved; the solution should appear clear. Do not shake.
- Label the vial and store refrigerated at 2–8 °C (35.6–46.4 °F), protected from light, and use within 2–4 weeks.
Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.
Supplies Needed
Plan based on research duration. Due to the 10 mg vial format, extended protocols require multiple vials.
- 5-Amino-1MQ Vials (10 mg each):
- 1 week (5 mg/day) ≈ 4 vials
- 2 weeks (5 mg/day) ≈ 7 vials
- 4 weeks (5 mg/day) ≈ 14 vials
- Insulin Syringes (U-100, 1 mL):
- Per week (once daily): 7 syringes
- Per week (BID): 14 syringes
- 4 weeks (once daily): 28 syringes
- Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
- 1 week (4 vials): 8 mL → 1 × 10 mL bottle
- 2 weeks (7 vials): 14 mL → 2 × 10 mL bottles
- 4 weeks (14 vials): 28 mL → 3 × 10 mL bottles
- Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
- Per week (once daily): 14 swabs
- 4 weeks (once daily): 56 swabs → recommend 1 × 100-count box
Protocol Overview
Brief summary of the subcutaneous dosing regimen.
- Goal: Support metabolic efficiency by inhibiting NNMT activity, with potential benefits for fat oxidation and intracellular NAD⁺ levels.
- Schedule: Subcutaneous injections administered daily; each vial typically provides approximately 2–4 days of research material.
- Dose Range: 2.5–5 mg administered once daily or divided into twice-daily dosing.
- Reconstitution: Add 2.0 mL of bacteriostatic water per 10 mg vial to achieve a concentration of 5 mg/mL for precise measurement.
- Storage: Store lyophilized material frozen at −20 °C (−4 °F); following reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F).
Dosing Protocol
Suggested approach for the 10 mg vial format.
- Start: 2.5 mg once daily to assess tolerance.
- Target: 5 mg once daily or 2.5 mg twice daily (BID).
- Frequency: Once or twice per day (subcutaneous).
- Vial Duration: Single 10 mg vial lasts 2–4 days at research doses.
- Timing: Morning administration preferred; BID dosing may be split AM/PM.
Storage Instructions
Proper storage preserves compound stability.
- Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.
- Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.
- Do not refreeze reconstituted solution.
Important Notes
Practical considerations for consistency and safety.
- Use new sterile insulin syringes for each administration; dispose in a sharps container.
- Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
- Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.
- Document daily dose and site rotation to maintain consistency.
- The 10 mg vial format is suited for short-term tolerance assessment; extended protocols require multiple vials.
How This Works
5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small-molecule compound that selectively inhibits nicotinamide N-methyltransferase (NNMT). NNMT is an enzyme responsible for methylating nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor. Under conditions such as obesity and metabolic dysfunction, NNMT is frequently overexpressed in adipose tissue, leading to increased nicotinamide depletion and reduced availability of NAD⁺.
Through inhibition of NNMT activity, 5-Amino-1MQ may preserve nicotinamide for NAD⁺ biosynthesis, which can in turn support activation of SIRT1 (Sirtuin 1) pathways involved in mitochondrial biogenesis and fat oxidation. Preclinical research suggests that NNMT suppression—either through knockdown or pharmacologic inhibition—may protect against diet-induced weight gain and improve metabolic markers without a corresponding reduction in food intake.
Potential Benefits & Side Effects
Findings reported in preclinical and early-stage research literature.
- May support reductions in fat mass while maintaining lean muscle in animal models.
- Linked with increased NAD⁺ levels and activation of SIRT1 pathways in preclinical studies.
- Improved grip strength has been observed in aged mice when combined with exercise interventions.
- Generally well tolerated, with occasional reports of mild headache, short-lived jitteriness, or localized injection-site reactions.
- Long-term safety data in human populations have not been established; the compound remains investigational.
Lifestyle Factors
Supportive strategies intended to complement overall outcomes.
- Pair with a balanced, protein-focused diet adjusted to individual energy requirements.
- Combine resistance-based training with aerobic activity; preclinical findings suggest potential synergy with exercise.
- Prioritize adequate sleep and effective stress management to support metabolic adaptation.
- Consider the use of complementary NAD⁺ precursor compounds (such as NMN or NR) in line with emerging stack-based protocols.
Injection Technique
General guidance for subcutaneous administration based on established clinical best-practice resources.
- Clean the vial stopper and the injection site with alcohol and allow both to dry completely.
- Gently pinch a fold of skin and insert the needle at an angle of 45–90° into the subcutaneous tissue.
- Aspiration is not required for subcutaneous injections; inject the solution slowly and steadily.
- Rotate injection sites in a systematic manner (abdomen, thighs, upper arms) to help prevent lipohypertrophy.
- Administering the injection slowly may help reduce any stinging sensation associated with the compound.
Recommended Source
We recommend Ion Peptide for high-purity 5-Amino-1MQ (10 mg).
Why Ion Peptide?
- High-purity material (≥99% by HPLC), supported by third-party testing and batch-specific certificates of analysis (COAs).
- Consistent handling and documentation aligned with ISO-style quality standards.
- Dependable fulfillment processes designed to preserve cold-chain integrity.
Important Note
This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.